Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J During

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Journal of Neurochemistry|August 1, 1989
Stimulation-induced release of coexistent transmitters in the prefrontal cortex: an in vivo microdialysis study of dopamine and neurotensin releaseA J Bean, M J During, R H Roth
Journal of Virology|November 23, 2000
High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmidsL Cao, Y Liu, M J During, et al.
Neuroscience Letters|October 31, 1988
Phenylalanine administration influences dopamine release in the rat's corpus striatumM J During, I N Acworth, R J Wurtman
Neuroscience Letters|January 1, 1990
Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortexA J Bean, M J During, R H Roth
Human Gene Therapy|September 1, 2001
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulationM J During, M G Kaplitt, M B Stern, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1990
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptorsK J Swartz, M J During, A Freese, et al.
Current Opinion in Molecular Therapeutics|November 21, 2001
Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan diseaseP Leone, C G Janson, S J McPhee, et al.
Neurology|April 1, 1990
Kynurenine metabolites of tryptophan: implications for neurologic diseasesA Freese, K J Swartz, M J During, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in ratsB A Sabel, P Dominiak, W Häuser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Combined injection of rAAV with mannitol enhances gene expression in the rat brainM Y Mastakov, K Baer, R Xu, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Journal of Neurochemistry|August 1, 1989
Stimulation-induced release of coexistent transmitters in the prefrontal cortex: an in vivo microdialysis study of dopamine and neurotensin releaseA J Bean, M J During, R H Roth
Journal of Virology|November 23, 2000
High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmidsL Cao, Y Liu, M J During, et al.
Neuroscience Letters|October 31, 1988
Phenylalanine administration influences dopamine release in the rat's corpus striatumM J During, I N Acworth, R J Wurtman
Neuroscience Letters|January 1, 1990
Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortexA J Bean, M J During, R H Roth
Human Gene Therapy|September 1, 2001
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulationM J During, M G Kaplitt, M B Stern, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1990
Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptorsK J Swartz, M J During, A Freese, et al.
Current Opinion in Molecular Therapeutics|November 21, 2001
Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan diseaseP Leone, C G Janson, S J McPhee, et al.
Neurology|April 1, 1990
Kynurenine metabolites of tryptophan: implications for neurologic diseasesA Freese, K J Swartz, M J During, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in ratsB A Sabel, P Dominiak, W Häuser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Combined injection of rAAV with mannitol enhances gene expression in the rat brainM Y Mastakov, K Baer, R Xu, et al.
Pageof 9